Literature DB >> 6146485

A comparative study of properties and toxic constituents of funnel web spider (Atrax) venoms.

D D Sheumack, B A Baldo, P R Carroll, F Hampson, M E Howden, A Skorulis.   

Abstract

The crude venoms of male and female Sydney funnel web spiders, Atrax robustus, were compared by cation-exchange and high-performance liquid chromatography, lethality to new-born mice, polyacrylamide gel isoelectric focusing, immunoelectrophoresis, phospholipase A analysis, effects on the mouse phrenic nerve hemidiaphragm and passive paw oedema in the rat and, except in the case of rat paw oedema, were found to exhibit quite different properties. Polyacrylamide gel isoelectric focusing and high-performance liquid chromatography proved to be suitable for gender and species determination when applied to the venoms of A. formidabilis, A. infensus, A. robustus and A. versutus. These venoms were also compared by lethality, promotion of muscle fasciculation and phospholipase A activity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6146485     DOI: 10.1016/0742-8413(84)90048-3

Source DB:  PubMed          Journal:  Comp Biochem Physiol C        ISSN: 0742-8413


  3 in total

1.  Amino acid sequence of versutoxin, a lethal neurotoxin from the venom of the funnel-web spider Atrax versutus.

Authors:  M R Brown; D D Sheumack; M I Tyler; M E Howden
Journal:  Biochem J       Date:  1988-03-01       Impact factor: 3.857

2.  Modification of sodium channel gating and kinetics by versutoxin from the Australian funnel-web spider Hadronyche versuta.

Authors:  G M Nicholson; M Willow; M E Howden; T Narahashi
Journal:  Pflugers Arch       Date:  1994-10       Impact factor: 3.657

3.  Immunization with a synthetic robustoxin derivative lacking disulphide bridges protects against a potentially lethal challenge with funnel-web spider (Atrax robustus) venom.

Authors:  Alfio Comis; Margaret Tyler; Ewan Mylecharane; Ian Spence; Merlin Howden
Journal:  J Biosci       Date:  2009-03       Impact factor: 1.826

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.